Endúr ASA (LON:0JGO)
85.00
0.00 (0.00%)
At close: Dec 12, 2025
Endúr ASA Revenue
Endúr ASA had revenue of 1.84B NOK in the quarter ending September 30, 2025, with 147.39% growth. This brings the company's revenue in the last twelve months to 5.17B, up 103.60% year-over-year. In the year 2024, Endúr ASA had annual revenue of 2.79B with 40.91% growth.
Revenue (ttm)
5.17B NOK
Revenue Growth
+103.60%
P/S Ratio
0.79
Revenue / Employee
6.74M NOK
Employees
767
Market Cap
304.40M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.79B | 809.20M | 40.91% |
| Dec 31, 2023 | 1.98B | -532.30M | -21.20% |
| Dec 31, 2022 | 2.51B | 501.40M | 24.96% |
| Dec 31, 2021 | 2.01B | 1.73B | 617.02% |
| Dec 31, 2020 | 280.20M | -54.30M | -16.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |